These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 35978450)
1. Metabolic syndrome in people with HIV from Guatemala: analysis of components and risk factors. Ortíz DW; Marroquin HE; Larson L; Franco KB; Spec A; Melendez JR; Pinzón R; Samayoa AJ; Mejia-Chew C; O Halloran JA Int J STD AIDS; 2022 Oct; 33(11):987-994. PubMed ID: 35978450 [TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome among treatment-naïve people living with and without HIV in Zambia and Zimbabwe: a cross-sectional analysis. Chihota BV; Mandiriri A; Shamu T; Muula G; Nyamutowa H; Taderera C; Mwamba D; Chilengi R; Bolton-Moore C; Bosomprah S; Egger M; Chimbetete C; Wandeler G; J Int AIDS Soc; 2022 Dec; 25(12):e26047. PubMed ID: 36522287 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and factors associated with metabolic syndrome in an urban population of adults living with HIV in Nairobi, Kenya. Kiama CN; Wamicwe JN; Oyugi EO; Obonyo MO; Mungai JG; Roka ZG; Mwangi A Pan Afr Med J; 2018; 29():90. PubMed ID: 29875971 [TBL] [Abstract][Full Text] [Related]
4. Evidence of increased STI/HIV-related risk behavior among male perpetrators of intimate partner violence in Guatemala: results from a national survey. Hembling J; Andrinopoulos K AIDS Care; 2014; 26(11):1411-8. PubMed ID: 25090474 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort. Berenguer J; Díez C; Martín-Vicente M; Micán R; Pérez-Elías MJ; García-Fraile LJ; Vidal F; Suárez-García I; Podzamczer D; Del Romero J; Pulido F; Iribarren JA; Gutiérrez F; Poveda E; Galera C; Izquierdo R; Asensi V; Portilla J; López JC; Arribas JR; Moreno S; González-García J; Resino S; Jarrín I Clin Microbiol Infect; 2021 Nov; 27(11):1678-1684. PubMed ID: 34186209 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307 [TBL] [Abstract][Full Text] [Related]
7. The burden of metabolic syndrome in patients living with HIV/AIDS receiving care at referral hospitals of Northwest Ethiopia: A hospital-based cross-sectional study, 2019. Gebrie A Diabetes Metab Syndr; 2020; 14(5):1551-1556. PubMed ID: 32947754 [TBL] [Abstract][Full Text] [Related]
8. Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study. Imoh LC; Ani CC; Iyua KO; Odo AI; Amusa GA; Osaigbovo GO; Isichei CO; Agbaji OO; Imade G; Zoakah AI; Okeahialam BN; Sagay AS Pan Afr Med J; 2020; 37():388. PubMed ID: 33796201 [TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and lifestyle factors among type 2 diabetes mellitus patients in Dessie Referral Hospital, Amhara region, Ethiopia. Zerga AA; Bezabih AM PLoS One; 2020; 15(11):e0241432. PubMed ID: 33137150 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Cardiometabolic Disease Risk Factors in People With HIV Initiating Antiretroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda. Amutuhaire W; Mulindwa F; Castelnuovo B; Brusselaers N; Schwarz JM; Edrisa M; Dujanga S; Salata RA; Yendewa GA Open Forum Infect Dis; 2023 Jun; 10(6):ofad241. PubMed ID: 37351455 [TBL] [Abstract][Full Text] [Related]
11. Association of HIV infection with metabolic syndrome among normal or underweight young adults: evidence from the CHART cohort. Shi R; Chen X; Lin H; Shen W; Xu X; Zhu B; Xu X; Ding Y; Wong FY; He N Biosci Trends; 2021 Jan; 14(6):450-456. PubMed ID: 33328394 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with HIV testing among men who have sex with men in Guatemala City. Morales-Miranda S; Loya-Montiel I; Ritter J; Rocha-Jiménez T; Gordon L; García J; Flores C; Silverman JG Int J STD AIDS; 2019 May; 30(6):577-585. PubMed ID: 30813861 [TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and 10-year cardiovascular risk among HIV-positive and HIV-negative adults: A cross-sectional study. Masyuko SJ; Page ST; Kinuthia J; Osoti AO; Polyak SJ; Otieno FC; Kibachio JM; Mogaka JN; Temu TM; Zifodya JS; Otedo A; Nakanjako D; Hughes JP; Farquhar C Medicine (Baltimore); 2020 Jul; 99(27):e20845. PubMed ID: 32629671 [TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia and its association with adiposity and dyslipidemia in Northwest China: results from cardiovascular risk survey in Xinjiang (CRS 2008-2012). Liu F; Du GL; Song N; Ma YT; Li XM; Gao XM; Yang YN Lipids Health Dis; 2020 Apr; 19(1):58. PubMed ID: 32238146 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross-sectional analysis. Savinelli S; De Francesco D; Feeney ER; Babalis D; Bagkeris E; Post FA; Boffito M; Williams I; Vera J; Johnson M; Anderson J; Sachikonye M; Winston A; Sabin C; Mallon P HIV Med; 2020 Aug; 21(7):441-452. PubMed ID: 32311831 [TBL] [Abstract][Full Text] [Related]
16. A Clinical Profile of Patients with Hyperuricemia and the Relationship between Hyperuricemia and Metabolic Syndrome: A Cross-sectional Study at a Tertiary Hospital in the Indian Population. Rajadhyaksha A; Sarate N; Raghorte N; Ingawale S J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598135 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Interaction between Hyperuricemia and Abdominal Obesity as a Risk Factor for Metabolic Syndrome Components in Korean Population. Lee MJ; Khang AR; Kang YH; Yun MS; Yi D Diabetes Metab J; 2022 Sep; 46(5):756-766. PubMed ID: 35045592 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia. Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435 [TBL] [Abstract][Full Text] [Related]
19. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia. Hailu GG; Wasihun AG BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891 [TBL] [Abstract][Full Text] [Related]
20. Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS. Shey MS; Kongnyuy EJ; Alobwede SM; Wiysonge CS Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD005481. PubMed ID: 23543540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]